Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy. | Cell Death Dis | 2026 | 41633975 | PubTator, text mining | PubMed |
| Exosomes in Hypertrophic Scars and Keloids: Mechanisms and Therapeutic Potentials-A Narrative Review. | J Cosmet Dermatol | 2026 | 41612955 | PubTator, text mining | PubMed |
| Comprehensive tumour-immune profiling reveals TREM2+ tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma. | Clin Transl Med | 2026 | 41612852 | PubTator, text mining | PubMed |
| Mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine: Standardisation, bioengineering and clinical translation. | Regen Ther | 2026 | 41537152 | PubTator, text mining | PubMed |
| TSG-6 Activated MSC-derived Extracellular Vesicles Present Altered micro-RNA Contents and Ameliorate the Inflammatory Phenotype of Macrophages in Vitro. | Inflammation | 2026 | 41526541 | PubTator, text mining | PubMed |
| Surface-Associated Proteins on Extracellular Vesicles Remodel the Tumor Microenvironment by Potentiating TGF-β Signaling in a Contact-Dependent Manner. | Adv Sci (Weinh) | 2026 | 41319267 | PubTator, text mining | PubMed |
| Integrated analysis of the transcriptome and proteome reveals that ABI3BP is involved in the pathogenesis of osteoarthritis. | J Proteomics | 2026 | 41232761 | PubTator, text mining | PubMed |
| Engineered 3D mesenchymal stem cell aggregates with multifunctional prowess for bone regeneration: Current status and future prospects. | J Adv Res | 2026 | 40220897 | PubTator, text mining | PubMed |
| Harnessing mesenchymal stromal cells for liver disease therapy: from mechanistic discoveries to clinical breakthroughs. | Front Med (Lausanne) | 2025 | 41717346 | PubTator, text mining | PubMed |
| The treatment of acute tendon injury with small extracellular vesicles originating from TNFAIP6- ADSCs subpopoulation both in vitro and in vivo. | Stem Cell Res Ther | 2025 | 41469712 | PubTator, text mining | PubMed |
Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1-3, and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) but Does Not Alter IL-17 Levels in Whole-Blood Cultures of Patients with Spondyloarthritis. | Int J Mol Sci | 2025 | 41465233 | PubTator, text mining | PubMed |
| Epigenetic memory as a readout of environmental susceptibility defines cell manufacturability in mesenchymal stem cell production. | Stem Cell Res Ther | 2025 | 41462383 | PubTator, text mining | PubMed |
| TSG-6 expression distinguishes rejected and non-rejected human lung transplants: a retrospective study. | Front Immunol | 2025 | 41425565 | PubTator, text mining | PubMed |
| Dietary supplementation with sodium isobutyrate enhances growth performance and colonic barrier function in weaned piglets via microbiota-metabolite-host interactions. | J Anim Sci Biotechnol | 2025 | 41354832 | PubTator, text mining | PubMed |
| Bioaugmented osteosynthesis: precise monitoring and intervention of the bone healing microenvironment. | Bone Res | 2025 | 41285741 | PubTator, text mining | PubMed |
| Utilising bioinformatics and molecular docking technology to explore the underlying mechanisms of intervertebral disc degeneration with potential therapeutic drugs and formulas. | J Glob Health | 2025 | 41267622 | PubTator, text mining | PubMed |
| Immortalized human hair follicle-derived mesenchymal-like stromal cells for the long-term production of scalable Immunomodulatory and regenerative secretome. | Stem Cell Res Ther | 2025 | 41250229 | PubTator, text mining | PubMed |
| CRISPR-mediated engineering of mesenchymal stromal/stem cells: a summary of recent progress in immunological applications for regenerative medicine and cancer therapy. | Stem Cell Res Ther | 2025 | 41163074 | PubTator, text mining | PubMed |
| Sex-specific gene expression and weighted co-expression network analysis suggest distinct sex-specific molecular signatures in acutely suicidal MDD-patients without somatic comorbidities. | Front Genet | 2025 | 41113358 | PubTator, text mining | PubMed |
| CLEC4E as a molecular biomarker in systemic lupus erythematosus: integrating bioinformatics and clinical data to assess its prognostic value. | Front Immunol | 2025 | 41098736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=3